Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. (Q31019088)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

0 references

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Andrew Nunn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

J P Zajicek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

H P Sanders

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

D E Wright

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P J Vickery

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

W M Ingram

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S M Reilly

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

L J Teare

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P J Fox

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neurology, Neurosurgery and Psychiatry

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1664-1669

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

9 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1739436

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1739436

Neuroprotection in Parkinson's disease: clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1739436

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1739436

Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1739436

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1739436

The perceived effects of smoked cannabis on patients with multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1739436

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1739436

21 June 2018

Identifiers

DOI

10.1136/JNNP.2005.070136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16291891%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference